WATSON 746 (Clonazepam 0.5 mg)

Pill imprint WATSON 746 has been identified as Clonazepam 0.5 mg.

Clonazepam is used in the treatment of anxiety; benzodiazepine withdrawal; bipolar disorder; chronic myofascial pain; restless legs syndrome (and more), and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Clonazepam 0.5 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.

See also related documents.

Imprint Search

Images for WATSON 746

Clonazepam 0.5 mg WATSON 746
Clonazepam 0.5 mg WATSON 746
Clonazepam
Imprint:
WATSON 746
Strength:
0.5 mg
Color:
Yellow
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Benzodiazepine anticonvulsants
Benzodiazepines
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0746
Inactive Ingredients:
docusate sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium benzoate
sodium starch glycolate
D&C Yellow No. 10 Aluminium Lake
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
55289-0599 PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)